DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,167 | -9.7% | 10,076 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $141,870 | -8.9% | 10,076 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $155,674 | +12.6% | 10,076 | +19.5% | 0.00% | 0.0% |
| Q4 2022 | $138,233 | -17.7% | 8,434 | -7.3% | 0.00% | 0.0% |
| Q3 2022 | $168,000 | +40.0% | 9,094 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $120,000 | +42.9% | 9,094 | 0.0% | 0.00% | – |
| Q1 2022 | $84,000 | -38.7% | 9,094 | -35.3% | 0.00% | -100.0% |
| Q4 2021 | $137,000 | +2.2% | 14,046 | +255.1% | 0.00% | 0.0% |
| Q3 2021 | $134,000 | -7.6% | 3,955 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $145,000 | -18.1% | 3,955 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $177,000 | -34.9% | 3,955 | -17.2% | 0.00% | -50.0% |
| Q4 2020 | $272,000 | +30.8% | 4,774 | +17.5% | 0.00% | +100.0% |
| Q3 2020 | $208,000 | -14.4% | 4,063 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $243,000 | +237.5% | 4,063 | +133.9% | 0.00% | +100.0% |
| Q1 2020 | $72,000 | -33.3% | 1,737 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $108,000 | +83.1% | 1,737 | 0.0% | 0.00% | – |
| Q3 2019 | $59,000 | +293.3% | 1,737 | +162.0% | 0.00% | – |
| Q2 2019 | $15,000 | – | 663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |